Banner

News

Article

Aidoc secures FDA clearance for AI-powered rib fracture detection

Author(s):

Key Takeaways

  • Aidoc's Rib Fractures triage solution, based on the CARE1 Foundation Model, has received FDA clearance, highlighting foundation models' role in clinical decision-making.
  • Foundation models like CARE1 enhance AI application accuracy and scalability, reducing development timelines from years to weeks.
SHOW MORE

Triage solution is built on existing AI engine

AI-powered rib fracture detection technology receives FDA clearance: ©Crystal Light - stock.adobe.com

AI-powered rib fracture detection technology receives FDA clearance: ©Crystal Light - stock.adobe.com

Aidoc has received FDA clearance for its Rib Fractures triage solution powered by a foundation model. This regulatory approval reinforces the growing role of foundation models in accelerating innovation and improving clinical decision-making, according to the company.

The newly cleared Rib Fractures triage solution is built on Aidoc’s CARE1 Foundation Model. By leveraging extensive datasets and vast computational resources, foundation models like CARE1 can enhance the accuracy and scalability of AI applications, significantly reducing development timelines from years to mere weeks, according to the company.

"A year ago, what we're seeing today seemed impossible. Now, it's happening faster than anyone expected," said Michael Braginsky, Aidoc’s Chief Technology Officer, in a statement. "Every major organization will soon have to decide: Build a foundation model or leverage one. As this shift accelerates, the real differentiator will be accuracy. Only the most accurate models will drive real impact."

This milestone follows Aidoc’s ongoing collaboration with Amazon Web Services, which has invested in advancing the company's aiOS platform and CARE Foundation Model technology. Aidoc is already developing the next iteration, CARE2, with a planned release in the coming months.

Unlike traditional AI models designed for specific tasks, foundation models like CARE1 offer scalability and adaptability, enabling quicker refinements and broader clinical applications, according to the company. These advancements have already attracted health care partners such as Mercy, which recently implemented Aidoc’s AI solutions across its enterprise.

"We partnered with Aidoc because they align with our enterprise vision and mission of better patient care," said Joe Kelly, Chief Transformation Officer at Mercy, in a statement. "Their seamless integration into clinical practice enhances daily decision-making, and their pace of innovation matches ours. This latest milestone affirms that Aidoc is a partner that can scale with us and support our organization-wide strategy."

As AI adoption in health care accelerates, Aidoc emphasizes the importance of infrastructure that enables seamless deployment and integration of AI tools. The company’s aiOS platform provides a unified system for managing AI solutions, reducing operational inefficiencies that can arise from fragmented implementations.

"The future of AI goes beyond simply creating smarter models—it's about seamlessly integrating, scaling, and delivering these innovations to end users," Braginsky added. "Our robust infrastructure lays the foundation for transformation, empowering medical professionals to set new standards of care while boosting efficiency."

Related Videos